Home > Healthcare > Medical Devices > Medical Supplies > Transplant Box Market

Transplant Box Market Share

Report ID: GMI8063
Published Date: Feb 2024
Report Format: PDF

Download Free Sample

Transplant Box Market Share

The transplant box industry is competitive in nature, with several large multinationals and small and mid-sized companies competing in the industry. The development and launch of novel advanced applications based on different technologies is among a key market strategy. Some of the leading industry players including Organ Recovery Systems, Thermo Fisher Scientific Inc., TransMedics Inc., among others have a notable presence in the market.

Transplant Box Market Companies

Some of the eminent market participants operating in the transplant box industry include:

Accord Healthcare Ltd.
BioLife Solutions Inc.
BioSpherix Ltd.
Dr. Franz Koehler Chemie GmbH
Medtronic plc
OrganOx Limited
Organ Recovery Systems
Paragonix Technologies, Inc.
Preservation Solution Inc.
Shanghai Genext Medical Technology Co. Ltd.
Thermo Fisher Scientific Inc.
ThermoGenesis Holdings Inc.
TransMedics Inc.
Transplant Systems Pty. Ltd.
XVIVO Perfusion AB

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The global transplant box industry was valued at around USD 169.5 million in 2023 and is estimated to reach over USD 337.2 million by 2032 owing to the ongoing advancements in transplant box, an increase in the prevalence of chronic diseases, and the continual surge in healthcare expenditure.

The kidney segment is estimated to account for USD 85.5 million in 2023 and will grow significantly through 2032 owing to the increasing incidence of chronic kidney diseases (CKD) and subsequent kidney failures.

North America transplant box market accounted for USD 68.7 million in 2023 and is predicted to witness substantial growth over 2024 and 2032 due to sophisticated healthcare infrastructure, a heightened prevalence of cardiovascular diseases, and swift technological progress.

Accord Healthcare Ltd., BioLife Solutions Inc., BioSpherix Ltd., dr. Franz Koehler Chemie GmbH, Medtronic plc, OrganOx Limited, Organ Recovery Systems, Paragonix Technologies, Inc., Preservation Solution Inc., Shanghai Genext Medical Technology Co. Ltd., Thermo Fisher Scientific Inc., ThermoGenesis Holdings Inc., TransMedics Inc., Transplant Systems Pty. Ltd., and XVIVO Perfusion AB.